Advagene Biopharma Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was TWD 92.69 million compared to TWD 70.16 million a year ago. Basic loss per share from continuing operations was TWD 1.9 compared to TWD 1.58 a year ago.